• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility tests.福提霉素A与其他五种氨基糖苷类药物的抗菌活性及影响药敏试验的因素
Antimicrob Agents Chemother. 1981 Jan;19(1):122-9. doi: 10.1128/AAC.19.1.122.
2
Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.化合物A49759,福提霉素A的3-O-去甲基衍生物:与其他六种氨基糖苷类抗生素的体外比较
Antimicrob Agents Chemother. 1980 Nov;18(5):773-9. doi: 10.1128/AAC.18.5.773.
3
Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides.新氨基糖苷类抗生素福提霉素A和B。IV. 福提霉素A与其他氨基糖苷类药物的体外研究。
J Antibiot (Tokyo). 1977 Jul;30(7):564-70. doi: 10.7164/antibiotics.30.564.
4
Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.福提霉素A的衍生物O-去甲基福提霉素A的抗菌活性比较
Antimicrob Agents Chemother. 1980 Nov;18(5):766-72. doi: 10.1128/AAC.18.5.766.
5
In vitro and in vivo antibacterial activities of K-4619, a new semisynthetic aminoglycoside.新型半合成氨基糖苷类药物K-4619的体外和体内抗菌活性
Antimicrob Agents Chemother. 1984 Aug;26(2):187-91. doi: 10.1128/AAC.26.2.187.
6
Preclinical comparative evaluation of aminoglycosides.氨基糖苷类药物的临床前比较评估。
Chemioterapia. 1984 Dec;3(6):378-84.
7
1-N HAPA gentamicin B, a new aminoglycoside active against gentamicin resistant isolates--activity compared to other aminoglycosides.
J Antibiot (Tokyo). 1978 May;31(5):385-93. doi: 10.7164/antibiotics.31.385.
8
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.福提霉素A:体外协同药敏性。与阿米卡星和庆大霉素针对11840株临床分离菌的比较。
Antimicrob Agents Chemother. 1979 Dec;16(6):823-8. doi: 10.1128/AAC.16.6.823.
9
3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.3 - O - 去甲基福提霉素A:纸片扩散法药敏试验的体外活性及解释性抑菌圈标准
Eur J Clin Microbiol. 1984 Dec;3(6):531-7. doi: 10.1007/BF02013613.
10
In vitro activity of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with activities of other aminoglycosides.新型假二糖氨基糖苷类药物达替米星的体外活性与其他氨基糖苷类药物活性的比较。
Antimicrob Agents Chemother. 1989 Nov;33(11):1998-2003. doi: 10.1128/AAC.33.11.1998.

引用本文的文献

1
Novel endophytic actinomycetes species Streptomyces panacea of Panax sokpayensis produce antimicrobial compounds against multidrug resistant Staphylococcus aureus.人参内生放线菌新种全缘叶人参链霉菌产生针对多重耐药金黄色葡萄球菌的抗菌化合物。
Sci Rep. 2025 Jun 5;15(1):19863. doi: 10.1038/s41598-025-05333-1.
2
Response Surface D-Optimal Design for Optimizing Fortimicins Production by Micromonospora olivasterospora and New Synergistic Fortimicin-A-Antibiotic Combinations.用于优化橄榄小单孢菌生产福提霉素的响应面D-最优设计及新型福提霉素A-抗生素协同组合
Curr Microbiol. 2025 Jan 3;82(2):68. doi: 10.1007/s00284-024-04049-1.
3
Central composite design for optimizing istamycin production by Streptomyces tenjimariensis.用中心复合设计优化棘孢小单孢菌产生棘霉素。
World J Microbiol Biotechnol. 2024 Sep 9;40(10):316. doi: 10.1007/s11274-024-04118-4.
4
Evaluation of fortimicin antibiotic combinations against MDR Pseudomonas aeruginosa and resistome analysis of a whole genome sequenced pan-drug resistant isolate.评价妥布霉素抗生素组合对多药耐药铜绿假单胞菌的作用及全基因组测序泛耐药分离株的耐药组分析。
BMC Microbiol. 2024 May 14;24(1):164. doi: 10.1186/s12866-024-03316-2.
5
Proposed zone standards for interpretation of fortimicin A disk diffusion tests.用于解读硫酸庆大霉素纸片扩散试验的拟议区域标准。
J Clin Microbiol. 1983 Aug;18(2):440-2. doi: 10.1128/jcm.18.2.440-442.1983.
6
Comparison of fortimicins with other aminoglycosides and effects on bacterial ribosome and protein synthesis.福提霉素与其他氨基糖苷类药物的比较及其对细菌核糖体和蛋白质合成的影响。
Antimicrob Agents Chemother. 1984 Dec;26(6):857-62. doi: 10.1128/AAC.26.6.857.
7
Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.奈替米星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1989 Nov;38(5):703-56. doi: 10.2165/00003495-198938050-00003.
8
Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.七种药敏试验方法检测铜绿假单胞菌氨基糖苷类药物结果存在广泛差异。
J Clin Microbiol. 1989 Oct;27(10):2277-85. doi: 10.1128/jcm.27.10.2277-2285.1989.

本文引用的文献

1
Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.庆大霉素B衍生物Sch 21420与阿米卡星、庆大霉素、奈替米星、西索米星和妥布霉素的体外活性比较。
Antimicrob Agents Chemother. 1980 Aug;18(2):338-45. doi: 10.1128/AAC.18.2.338.
2
Fortimicins A and B, new aminoglycoside antibiotics. I. Producing organism, fermentation and biological properties of fortimicins.新氨基糖苷类抗生素福提霉素A和B。I. 福提霉素的产生菌、发酵及生物学特性
J Antibiot (Tokyo). 1977 Jul;30(7):533-40. doi: 10.7164/antibiotics.30.533.
3
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.福提霉素A:体外协同药敏性。与阿米卡星和庆大霉素针对11840株临床分离菌的比较。
Antimicrob Agents Chemother. 1979 Dec;16(6):823-8. doi: 10.1128/AAC.16.6.823.
4
Enzymatic acetylation of fortimicin A and seldomycin factor 5 by aminoglycoside 3-acetyltransferase I: [AAC(3)-I] of E. coli KY8348.大肠杆菌KY8348的氨基糖苷3 - 乙酰转移酶I [AAC(3)-I]对福提霉素A和塞尔多霉素因子5的酶促乙酰化作用
J Antibiot (Tokyo). 1977 Nov;30(11):1025-7. doi: 10.7164/antibiotics.30.1025.
5
Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides.新氨基糖苷类抗生素福提霉素A和B。IV. 福提霉素A与其他氨基糖苷类药物的体外研究。
J Antibiot (Tokyo). 1977 Jul;30(7):564-70. doi: 10.7164/antibiotics.30.564.
6
Fortimicins A and B, new aminoglycoside antibiotics. II. Isolation, physico-chemical and chromatographic properties.
J Antibiot (Tokyo). 1977 Jul;30(7):541-51. doi: 10.7164/antibiotics.30.541.

福提霉素A与其他五种氨基糖苷类药物的抗菌活性及影响药敏试验的因素

Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility tests.

作者信息

Thornsberry C, Barry A L, Jones R N, Baker C N, Badal R E, Packer R R

出版信息

Antimicrob Agents Chemother. 1981 Jan;19(1):122-9. doi: 10.1128/AAC.19.1.122.

DOI:10.1128/AAC.19.1.122
PMID:7247351
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC181369/
Abstract

Fortimicin A, a pseudodisaccharide aminoglycoside, was found to have broad-spectrum activity against most clinically important aerobic and facultatively anaerobic bacteria, except Pseudomonas aeruginosa, some other Pseudomonas species, and streptococci. It was comparable to amikacin in its level of activity (minimum inhibitory concentrations) and spectrum of activity (except for the lack of activity on P. aeruginosa). Fortimicin A was bactericidal and was affected by cations when tested against P. aeruginosa. Minimum inhibitory concentrations were affected by the inoculum used in the susceptibility test. The drug was resistant to most aminoglycoside-inactivating enzymes, but probably is not active against permeability mutants.

摘要

福提霉素A是一种假二糖氨基糖苷类抗生素,已发现它对大多数临床上重要的需氧菌和兼性厌氧菌具有广谱活性,但对铜绿假单胞菌、其他一些假单胞菌属细菌以及链球菌除外。其活性水平(最低抑菌浓度)和活性谱与阿米卡星相当(除了对铜绿假单胞菌无活性)。福提霉素A具有杀菌作用,在针对铜绿假单胞菌进行测试时受阳离子影响。最低抑菌浓度受药敏试验中所用接种物的影响。该药物对大多数氨基糖苷类失活酶具有抗性,但可能对通透性突变体无活性。